High Intensity Aerobic Interval Training Versus Continuous Training in Heart Failure Patients.

Sponsor
Riphah International University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05948371
Collaborator
(none)
62
2
2
5
31
6.2

Study Details

Study Description

Brief Summary

To determine the effect of high intensity aerobic interval training versus continuous aerobic training in heart failure patients.

Condition or Disease Intervention/Treatment Phase
  • Other: High Intensity interval Training
  • Other: Continuous Aerobic training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of High Intensity Aerobic Interval Training Versus Continuous Training in Heart Failure Patients.
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: High Intensity interval Training

Other: High Intensity interval Training
High Intensity interval Training Frequency: 3-5 day per week Intensity: 60 to 80% of HRR. If atrial fibrillation present use RPE of 11-14 on a 6-20 scale. Time: total 30 mint time.6 mint exercise with high intensity and 2 mints of low intensity for active recovery until 30 mints complete. Type: walking and static cycling. Walking Frequency 3 -5 days per week Intensity : use RPE of 11-14. Time:30 mint total. 6 mint walk with high intensity and 2 mint walk with low intensity until 30mints completed.

Active Comparator: Continuous Aerobic training

Other: Continuous Aerobic training
Continuous Aerobic training Frequency : 3-5 days per week. Intensity:40-70% of HHR. Time : initial 5-10 then 10-15 until 30mints without rest interval Type : walking and static cycling.

Outcome Measures

Primary Outcome Measures

  1. 6MWT Distance [8 week]

    Changes from the baseline, 6 min walk test was used to measure Functional capacity. It is a sub maximal exercise test which can aid in assessing functional capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters which an individual covers in 6 min.

  2. Minnesota living with heart failure questionnaire [8 week]

    MLWHFQ is commonly used health related quality of life questionnaires with heart failure. This is very easy to apply on patients and self-administered questionnaire. It has two components emotional and physical and total score. Each item is scored in a 6.likert scale (0 to 5), thus, the total score could range from 5 to 105, with higher scores indicating more significant impairment in health related quality of life. Changes from the basline will be measured

  3. Pulse Rate [8 week]

    Changes from baseline, Pulse rate was measured per minute through pulse oximeter

  4. Oxygen Saturation (SpO2) [8 week]

    Changes from baseline SPO2 was measured in percentage. Oxygen immersion is the division of oxygen-soaked hemoglobin with respect to add up to hemoglobin in the blood. Pulse oximeter measure it.

  5. Modified Borg dyspnea scale [8 week]

    Changes from the Baseline, It is a subjective numeric scale ranging from 0 to 10, where 0 indicates "no dyspnea" and 10 indicates "unbearable dyspnea." A number is chosen by the patient in order to decide the best score that matches his level of dyspnea during physical activity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient with heart failure including both male and female

  • Patients who can perform 6 MWT.

  • According to classification of American heart association, class 1 heart failure patients are included.

Exclusion Criteria:
  • Heart failure patients along with orthopedic problems.

  • Patients who have use pacemaker.

  • Patient who have recent acute myocardial infraction or revascularization less than 3 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Poly clinic Hospital Islamabad Fedral Pakistan 44000
2 Railway General Hospital Rawalpindi Punjab Pakistan 44000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Muhammad Iqbal Tariq, PhD*, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05948371
Other Study ID Numbers:
  • Hafiza Misbah Inayat
First Posted:
Jul 17, 2023
Last Update Posted:
Jul 17, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 17, 2023